Claims for Patent: 5,824,870

Summary for Patent: 5,824,870

Title:	Commercial production of aprotinin in plants
Abstract:	A method for commercial production of aprotinin entails heterologous expression of the protein in plants, preferably at a level such that aprotinin accounts for at least 0.1% of the total extracted protein. An aprotinin-expressing plant also has potential of increased insecticidal resistance by virtue of producing the protein. A genetic map of the integration locus allows identification of plants derived from the transgenic plant. This approach also reveals genetic loci on a plant chromosome that support high levels of gene expression and can be used as site of integration for expression of other genes of interest.
Inventor(s):	Baszczynski; Chris (Urbandale, IA), Czapla; Thomas (Urbandale, IA), Hood; Elizabeth (Clive, IA), Meyer; Terry EuClaire (Urbandale, IA), Peterson; David (Johnston, IA), Rao; A. Gururaj (Urbandale, IA), Register, III; James C. (Ames, IA), Witcher; Derrick (Urbandale, IA), Howard; John A. (West Des Moines, IA)
Assignee:
Application Number:	08/554,161
Patent Claims:	1. An isolated DNA molecule comprising a heterologous nucleotide sequence encoding aprotinin operably linked to a promoter sequence to allow its expression in plants. 2. The DNA molecule of claim 1, wherein said molecule further comprises a selection marker gene operably linked to a promoter sequence to allow its expression in plants. 3. A DNA molecule according to claim 1, wherein said aprotinin-encoding sequence incorporates plant-preferred codons. 4. A DNA molecule according to claim 1, wherein said molecule further comprises an intron sequence or a peptide export signal sequence which modifies expression of said aprotinin-encoding sequence. 5. An isolated DNA molecule according to claim 4, wherein said export signal sequence is a barley alpha amylase peptide export signal sequence. 6. An isolated DNA molecule according to claim 4, wherein said intron sequence is a plant ubiquitin intron sequence. 7. A transgenic plant stably transformed with a DNA molecule comprising a heterologous nucleotide sequence encoding aprotinin operably linked to a promoter sequence to allow its expression in plants such that the aprotinin expressed in the plant is capable of protease inhibition. 8. A transgenic plant according to claim 7, wherein said plant is a corn plant. 9. A transgenic plant according to claim 7, wherein at least 0.1% of total extracted protein is aprotinin. 10. A transgenic plant according to claim 7, wherein said plant is of strain 46969, germplasm of which strain has been deposited under ATCC Accession No. 97327. 11. A method of producing aprotinin in commercial quantities, comprising extracting aprotinin form a biomass of a plurality of plants, wherein at least some of the plants of the plurality express a DNA molecule comprised of a heterologous aprotinin-encoding nucleotide sequence and a promoter operably linked to said aprotinin-encoding sequence to effect expression of aprotinin. 12. The method according to claim 11 wherein said biomass is comprised of seed. 13. The method according to claim 11 wherein at least 0.1% of total extracted protein in said biomass is aprotinin.

Details for Patent 5,824,870

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bayer Healthcare Pharmaceuticals Inc.	TRASYLOL	aprotinin	Injection	020304	12/29/1993		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26